Jayant K. Rane

3.3k total citations
16 papers, 566 citations indexed

About

Jayant K. Rane is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Jayant K. Rane has authored 16 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Jayant K. Rane's work include Prostate Cancer Treatment and Research (8 papers), Cancer Cells and Metastasis (4 papers) and Cancer, Lipids, and Metabolism (2 papers). Jayant K. Rane is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Cancer Cells and Metastasis (4 papers) and Cancer, Lipids, and Metabolism (2 papers). Jayant K. Rane collaborates with scholars based in United Kingdom, Finland and United States. Jayant K. Rane's co-authors include Norman J. Maitland, Chi Wai Eric So, Tsz Kan Fung, Anne T. Collins, Tapio Visakorpi, Amanda Wilson, Maria Teresa Esposito, Bernd B. Zeisig, Nadine Martin and Davide Pellacani and has published in prestigious journals such as Nature Medicine, Nature Genetics and Cancer Cell.

In The Last Decade

Jayant K. Rane

15 papers receiving 565 citations

Peers

Jayant K. Rane
Brendon Ladd United States
Sophia X. Pfister United Kingdom
T. David Soong United States
Milena Vuica‐Ross United States
Joseph R. Boyd United States
Tal Salz United States
Youyou Zhang United States
Pushpinder Bawa United States
Jayant K. Rane
Citations per year, relative to Jayant K. Rane Jayant K. Rane (= 1×) peers Haithem Barbour

Countries citing papers authored by Jayant K. Rane

Since Specialization
Citations

This map shows the geographic impact of Jayant K. Rane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayant K. Rane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayant K. Rane more than expected).

Fields of papers citing papers by Jayant K. Rane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayant K. Rane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayant K. Rane. The network helps show where Jayant K. Rane may publish in the future.

Co-authorship network of co-authors of Jayant K. Rane

This figure shows the co-authorship network connecting the top 25 collaborators of Jayant K. Rane. A scholar is included among the top collaborators of Jayant K. Rane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayant K. Rane. Jayant K. Rane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jones, Christopher M., et al.. (2025). Biomimetic models in radiotherapy research: An essential bridge between bench and beam. Cancer Cell. 43(7). 1186–1190.
2.
Rane, Jayant K., Alexander M. Frankell, Clare E. Weeden, & Charles Swanton. (2023). Clonal Evolution in Healthy and Premalignant Tissues: Implications for Early Cancer Interception Strategies. Cancer Prevention Research. 16(7). 369–378. 10 indexed citations
3.
Maitland, Norman J., et al.. (2019). Resolution of Cellular Heterogeneity in Human Prostate Cancers: Implications for Diagnosis and Treatment. Advances in experimental medicine and biology. 1164. 207–224. 7 indexed citations
4.
Khan, Khurum, Jayant K. Rane, David Cunningham, et al.. (2018). Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience. Clinical Colorectal Cancer. 18(1). 64–71.e1. 11 indexed citations
5.
Rošić, Silvana, Rachel Amouroux, Cristina E. Requena, et al.. (2018). Evolutionary analysis indicates that DNA alkylation damage is a byproduct of cytosine DNA methyltransferase activity. Nature Genetics. 50(3). 452–459. 66 indexed citations
6.
Cheung, Ngai, Tsz Kan Fung, Bernd B. Zeisig, et al.. (2016). Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia. Cancer Cell. 29(1). 32–48. 124 indexed citations
7.
Rane, Jayant K., Holger H.H. Erb, Giovanna Nappo, et al.. (2016). Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers. Oncotarget. 7(32). 51965–51980. 35 indexed citations
8.
Zoni, Eugenio, Geertje van der Horst, Jayant K. Rane, et al.. (2015). miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression. Cancer Research. 75(11). 2326–2336. 83 indexed citations
9.
Esposito, Maria Teresa, Lu Zhao, Tsz Kan Fung, et al.. (2015). Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors. Nature Medicine. 21(12). 1481–1490. 122 indexed citations
10.
Rane, Jayant K., Antti Ylipää, Rachel Adamson, et al.. (2015). Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data. British Journal of Cancer. 113(4). 611–615. 6 indexed citations
11.
Khanna, Anchit, Jayant K. Rane, Kati Kivinummi, et al.. (2015). CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations. Oncotarget. 6(23). 19661–19670. 25 indexed citations
12.
Santer, Frédéric R., Holger H.H. Erb, Su Jung Oh, et al.. (2015). Abstract 3: Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy. Cancer Research. 75(15_Supplement). 3–3. 5 indexed citations
13.
Santer, Frédéric R., Holger H.H. Erb, Su Jung Oh, et al.. (2015). Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy. Oncotarget. 6(8). 6105–6122. 29 indexed citations
14.
Rane, Jayant K., Alastair Droop, Davide Pellacani, et al.. (2014). Conserved Two-Step Regulatory Mechanism of Human Epithelial Differentiation. Stem Cell Reports. 2(2). 180–188. 16 indexed citations
15.
Rane, Jayant K., Davide Pellacani, & Norman J. Maitland. (2012). Advanced prostate cancer—a case for adjuvant differentiation therapy. Nature Reviews Urology. 9(10). 595–602. 26 indexed citations
16.
Rane, Jayant K., Davide Pellacani, Alastair Droop, et al.. (2012). Abstract 5198: Elucidation of dynamic prostate epithelial hierarchy: Insights into transcriptional and epigenetic regulatory mechanisms. Cancer Research. 72(8_Supplement). 5198–5198. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026